Reduced levels of cathepsin D associated with tamoxifen resistance and estrogen independence in the ZR-75-1 human breast cancer cell line

Cancer Letters

Volumn 99, Issue 2, 1996, Pages 233-238

  Long, Brian J ^a   Van Den Berg, Hendrik W ^b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; Cathepsin D; Hormone independence tamoxifen resistance; Western blotting

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; CATHEPSIN D; ESTRADIOL; ESTROGEN; GESTAGEN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; ELECTROPHORESIS; HORMONAL REGULATION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION;

EID: 0030025371     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04098-6     Document Type: Article

References (26)

1. Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet, 339, 1-15, 71-85.
2. Leonessa, F., Boulay, V., Wright, A., Thompson, E.W., Brünner, N. and Clarke, R. (1992) The biology of breast tumor progression: acquisition of hormone-independence and resistance to cytotoxic drugs. Acta Oncol., 31, 115-123.
3. Nicholson, S., Halcrow, P., Farndon, J.R., Sainsbury, J.R.C., Chambers, P. and Harris, A.L. (1989) Expression of epidermal growth factor receptors associated with lack of response of endocrine therapy in recurrent breast cancer. Lancet, i, 182-184.
4. Fernö, M., Baldetorp, B., Borg, A., Brouillet, J-P., Olsson, H., Rochefort, H., Sellberg, G., Sigurdsson, H. and Killander, D. For the South Sweden Breast Cancer Group (1994) Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. Eur. J. Cancer, 30A, 2042-2048.
5. Westley, B. and Rochefort, H. (1980) A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20, 353-362.
6. Spyratos, F., Maudelonde, T., Brouillet, J.-P., Brunet, M., Defrenne, A., Andrieu, C., Hacene, K., Desplaces, A., Rouesse, J. and Rochefort, H. (1989) Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet, ii, 1115-1118.
7. r 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res., 49, 6008-6014.
8. Capony, F., Rougeot, C., Montcourrier, P., Cavailles, V., Salazar, G. and Rochefort, H. (1989) Increased secretion, altered processing and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res., 49, 3904-3909.
9. Domagala, W., Striker, G., Szadowska, A., Dukowicz, A., Weber, K. and Osborn, M. (1992) Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years. Am. J. Pathol., 141, 1003-1012.
10. Winstanley, J.H.R., Leinster, S.J., Cooke, T.G., Westley, B.R., Platt-Higgins, A.M. and Rudland, P.S. (1993) Prognostic significance of cathepsin D in patients with breast cancer. Br. J. Cancer, 67, 767-772.
11. Henry, J.A., McCarthy, A.L., Angus, B., Westley, B.R., May, F.E.B., Nicholson, S., Cairns, J., Harris, A.L. and Home, C.H.W. (1990) Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: an immunohistochemical study. Cancer, 65, 265-271.
12. van den Berg, H.W., Lynch, M., Martin, J., Nelson, J., Dickson, G.R. and Crockard, A.D. (1989) Characterization of a tamoxifen resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotype. Br. J. Cancer, 59, 522-526.
13. van den Berg, H.W., Martin, J. and Lynch, M. (1990) High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. Br. J. Cancer, 61, 504-507.
14. Long, B., McKibben, B.M., Lynch, M. and van den Berg, H.W. (1992) Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. Br. J. Cancer, 65, 865-869.
15. Jarosz, D.E., Hamer, P.J., Tenney, D.Y. and Zabrecky, J.R. (1995) Elevated levels of pro-cathepsin D in the plasma of breast cancer patients. Int. J. Oncol., 6, 859-865.
16. Bonner, W.M. and Laskey, R.A. (1974) A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur. J. Biochem., 46, 83-88.
17. Stewart, A.J., Piggott, N.H., May, F.E.B. and Westley, B.R. (1994) Mitogenic activity of procathepsin D purified from conditioned medium of breast cancer cells by affinity chromatography on pepstatinyl agarose. Int. J. Cancer, 57, 715-718.
18. Isola, J., Weitz, S., Visakorpi, T., Holli, K., Shea, R., Khabbaz, N. and Kallioniemo, O-P. (1993) Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J. Clin. Oncol., 11, 36-43.
19. Joensuu, H., Toikanen, S. and Isola, J. (1995) Stromal cell cathepsin D expression and long-term survival in breast cancer. Br. J. Cancer, 71, 155-159.
20. O'Donoghue, A.E.M.A., Poller, D.N., Bell, J.A., Galea, M.H., Elston, C.W., Blamey, R.W. and Ellis, I.O. (1995) Cathepsin D in primary breast cancer: adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat., 33, 137-145.
21. Johnson, M.D., Torri, J.A., Lippman, M.E. and Dickson, R.B. (1993) The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res., 53, 873-877.
22. R-1. Cancer Res., 54, 1587-1595.
23. Clarke, R., Brünner, N., Katzenellenbogen, B.S., Thompson, E. W., Norman, M.J., Koppi, C., Paik, S., Lippman, M.E. and Dickson, R.B. (1989) Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc. Natl. Acad. Sic. USA, 86, 3649-3653.
24. Brünner, N., Boulay, V., Fojo, A., Freter, C.E., Lippman, M.E. and Clarke, R. (1993) Acquisation of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res., 53, 283-290.
25. Thompson, E.W., Brünner, N., Torri, J., Johnson, M.D., Boulay, V., Wright, A., Lippman, M.E., Steeg, P.S. and Clarke, R. (1993) The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin. Exp. Metastasis, 11, 15-26.
26. Clark, G.M. and McGuire, W.L. (1983) Progesterone receptors and human breast cancer. Breast Cancer Res. Treat., 3, 157-163.